Hyponatremia Associated with 3,4-Methylenedioxymethylamphetamine (“Ecstasy”) Abuse
- 1 August 2003
- journal article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 326 (2) , 89-93
- https://doi.org/10.1097/00000441-200308000-00006
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Acute hyponatraemia and 'ecstasy': insights from a quantitative and integrative analysisQJM: An International Journal of Medicine, 2002
- Ecstasy Experts Want Realistic MessagesJAMA, 2001
- Agony and ecstasy: a review of MDMA effects and toxicityEuropean Psychiatry, 2000
- The Urine/Plasma Electrolyte Ratio: A Predictive Guide to Water RestrictionThe Lancet Healthy Longevity, 2000
- Hyponatraemia in a neurosurgical patient: syndrome of inappropriate antidiuretic hormone secretion versus cerebral salt wastingNephrology Dialysis Transplantation, 2000
- Cerebral Salt-Wasting Syndrome: Does It Exist?Nephron, 1999
- Regulation of renal urate excretion: A critical reviewAmerican Journal of Kidney Diseases, 1998
- Low-dose MDMA (“ecstasy”) induces vasopressin secretionThe Lancet, 1998
- Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA)The Lancet, 1996
- Hyponatraemia and catatonic stupor after taking "ecstasy".BMJ, 1993